Biolinerx Stock Price History
| BLRX Stock | USD 4.47 0.18 3.87% |
Below is the normalized historical share price chart for BioLineRx extending back to July 25, 2011. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of BioLineRx stands at 4.47, as last reported on the 20th of July, with the highest price reaching 4.69 and the lowest price hitting 4.46 during the day.
If you're considering investing in BioLineRx Stock, it is important to understand the factors that can impact its price. BioLineRx appears to be moderately volatile, given 3 months investment horizon. BioLineRx secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of risk over the last 3 months. By analyzing BioLineRx's technical indicators, you can evaluate if the expected return of 0.94% is justified by implied risk. Please makes use of BioLineRx's Risk Adjusted Performance of 0.1251, downside deviation of 5.99, and Mean Deviation of 4.36 to double-check if our risk estimates are consistent with your expectations.
At this time, BioLineRx's Common Stock Shares Outstanding is fairly stable compared to the past year. Common Stock is likely to rise to about 40 M in 2025, whereas Total Stockholder Equity is likely to drop slightly above 12.8 M in 2025. . At this time, BioLineRx's Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 1.81 in 2025, whereas Price To Sales Ratio is likely to drop 0.70 in 2025. BioLineRx Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of July 2011 | 200 Day MA 7.7924 | 50 Day MA 4.2212 | Beta 0.901 |
BioLineRx | Build AI portfolio with BioLineRx Stock |
Sharpe Ratio = 0.1271
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BLRX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.39 actual daily | 66 66% of assets are less volatile |
Expected Return
| 0.94 actual daily | 18 82% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average BioLineRx is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioLineRx by adding it to a well-diversified portfolio.
Price Book 0.7973 | Enterprise Value Ebitda 0.4686 | Price Sales 0.7445 | Shares Float 2.1 B | Wall Street Target Price 26 |
BioLineRx Stock Price History Chart
There are several ways to analyze BioLineRx Stock price data. The simplest method is using a basic BioLineRx candlestick price chart, which shows BioLineRx price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | June 9, 2025 | 5.93 |
| Lowest Price | April 23, 2025 | 3.0 |
BioLineRx July 20, 2025 Stock Price Synopsis
Various analyses of BioLineRx's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell BioLineRx Stock. It can be used to describe the percentage change in the price of BioLineRx from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of BioLineRx Stock.| BioLineRx Price Action Indicator | (0.20) | |
| BioLineRx Price Rate Of Daily Change | 0.96 | |
| BioLineRx Price Daily Balance Of Power | (0.78) |
BioLineRx July 20, 2025 Stock Price Analysis
BioLineRx Stock Price History Data
The price series of BioLineRx for the period between Mon, Apr 21, 2025 and Sun, Jul 20, 2025 has a statistical range of 3.18 with a coefficient of variation of 20.93. The prices are distributed with arithmetic mean of 4.01. The median price for the last 90 days is 4.1. The company had 1:40 stock split on 30th of January 2025. BioLineRx issued dividends on 2019-07-15.| Open | High | Low | Close | Volume | ||
07/20/2025 | 4.60 | 4.69 | 4.46 | 4.47 | ||
| 07/18/2025 | 4.60 | 4.69 | 4.46 | 4.47 | 24,066 | |
07/17/2025 | 4.59 | 4.74 | 4.55 | 4.65 | 12,947 | |
07/16/2025 | 4.70 | 4.70 | 4.47 | 4.60 | 19,077 | |
07/15/2025 | 4.58 | 4.72 | 4.51 | 4.52 | 22,029 | |
07/14/2025 | 4.60 | 4.86 | 4.40 | 4.70 | 36,514 | |
07/11/2025 | 4.86 | 4.91 | 4.63 | 4.70 | 41,351 | |
07/10/2025 | 4.91 | 5.06 | 4.74 | 4.88 | 55,813 | |
07/09/2025 | 4.28 | 4.92 | 4.28 | 4.92 | 69,222 | |
07/08/2025 | 4.25 | 4.39 | 4.14 | 4.33 | 28,828 | |
07/07/2025 | 4.48 | 4.62 | 4.05 | 4.32 | 53,669 | |
07/03/2025 | 4.62 | 4.63 | 4.39 | 4.49 | 36,037 | |
| 07/02/2025 | 4.53 | 4.64 | 4.35 | 4.61 | 35,813 | |
07/01/2025 | 4.57 | 4.57 | 4.41 | 4.53 | 20,453 | |
06/30/2025 | 4.48 | 4.64 | 4.35 | 4.57 | 31,144 | |
06/27/2025 | 4.40 | 4.64 | 4.20 | 4.43 | 52,110 | |
06/26/2025 | 4.55 | 4.55 | 4.25 | 4.40 | 54,237 | |
06/25/2025 | 4.56 | 4.62 | 4.33 | 4.49 | 51,126 | |
06/24/2025 | 4.07 | 4.60 | 4.01 | 4.44 | 112,723 | |
06/23/2025 | 4.23 | 4.23 | 3.79 | 4.00 | 148,109 | |
06/20/2025 | 4.62 | 4.67 | 4.15 | 4.24 | 91,161 | |
06/18/2025 | 4.41 | 4.65 | 4.41 | 4.57 | 56,733 | |
| 06/17/2025 | 4.63 | 4.93 | 4.34 | 4.42 | 206,987 | |
06/16/2025 | 4.85 | 5.05 | 4.54 | 4.67 | 93,839 | |
06/13/2025 | 5.18 | 5.27 | 4.53 | 4.69 | 165,994 | |
06/12/2025 | 5.11 | 5.40 | 5.10 | 5.29 | 145,325 | |
06/11/2025 | 5.54 | 5.94 | 5.30 | 5.44 | 258,264 | |
06/10/2025 | 5.72 | 6.59 | 5.70 | 5.82 | 413,962 | |
06/09/2025 | 6.32 | 6.32 | 5.92 | 5.93 | 587,966 | |
06/06/2025 | 5.17 | 6.45 | 5.08 | 5.74 | 966,539 | |
06/05/2025 | 4.65 | 5.50 | 4.49 | 5.27 | 273,521 | |
06/04/2025 | 4.06 | 4.73 | 4.00 | 4.66 | 267,366 | |
06/03/2025 | 4.03 | 4.47 | 3.88 | 4.22 | 334,484 | |
06/02/2025 | 5.16 | 5.23 | 4.05 | 4.10 | 734,870 | |
| 05/30/2025 | 5.87 | 7.77 | 4.90 | 5.25 | 36,500,014 | |
05/29/2025 | 3.82 | 3.99 | 3.76 | 3.79 | 46,329 | |
| 05/28/2025 | 3.87 | 3.87 | 3.63 | 3.79 | 19,295 | |
05/27/2025 | 3.62 | 3.86 | 3.43 | 3.68 | 45,020 | |
05/23/2025 | 3.70 | 3.77 | 3.42 | 3.66 | 25,273 | |
05/22/2025 | 3.62 | 3.97 | 3.32 | 3.80 | 83,930 | |
05/21/2025 | 3.60 | 3.66 | 3.45 | 3.63 | 29,068 | |
05/20/2025 | 3.27 | 3.68 | 3.19 | 3.64 | 89,316 | |
05/19/2025 | 3.07 | 3.29 | 3.07 | 3.27 | 12,697 | |
05/16/2025 | 3.24 | 3.26 | 3.06 | 3.24 | 15,531 | |
05/15/2025 | 3.09 | 3.16 | 3.01 | 3.09 | 12,848 | |
05/14/2025 | 3.20 | 3.25 | 3.08 | 3.09 | 11,417 | |
05/13/2025 | 3.15 | 3.24 | 3.11 | 3.19 | 11,368 | |
05/12/2025 | 3.15 | 3.16 | 3.01 | 3.09 | 14,901 | |
| 05/09/2025 | 3.16 | 3.35 | 3.13 | 3.17 | 6,278 | |
05/08/2025 | 3.27 | 3.28 | 3.13 | 3.16 | 11,454 | |
05/07/2025 | 3.14 | 3.22 | 3.14 | 3.16 | 8,931 | |
05/06/2025 | 3.30 | 3.30 | 3.13 | 3.28 | 23,780 | |
05/05/2025 | 3.43 | 3.43 | 3.24 | 3.25 | 18,435 | |
05/02/2025 | 3.47 | 3.49 | 3.30 | 3.44 | 14,625 | |
05/01/2025 | 3.48 | 3.49 | 3.30 | 3.44 | 14,776 | |
04/30/2025 | 3.18 | 3.49 | 3.18 | 3.47 | 40,415 | |
04/29/2025 | 3.24 | 3.30 | 3.16 | 3.22 | 10,645 | |
04/28/2025 | 3.28 | 3.28 | 3.08 | 3.19 | 11,334 | |
04/25/2025 | 3.06 | 3.28 | 3.06 | 3.22 | 34,555 | |
04/24/2025 | 3.00 | 3.07 | 2.93 | 3.00 | 14,135 | |
04/23/2025 | 2.89 | 3.09 | 2.87 | 3.00 | 17,041 |
About BioLineRx Stock history
BioLineRx investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BioLineRx is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BioLineRx will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BioLineRx stock prices may prove useful in developing a viable investing in BioLineRx
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 79.9 M | 83.9 M | |
| Net Loss | -24.3 M | -25.6 M |
BioLineRx Quarterly Net Working Capital |
|
BioLineRx Stock Technical Analysis
BioLineRx technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
BioLineRx Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for BioLineRx's price direction in advance. Along with the technical and fundamental analysis of BioLineRx Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BioLineRx to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1251 | |||
| Jensen Alpha | 0.7964 | |||
| Total Risk Alpha | (0.12) | |||
| Sortino Ratio | 0.1276 | |||
| Treynor Ratio | 1.19 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for BioLineRx Stock Analysis
When running BioLineRx's price analysis, check to measure BioLineRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLineRx is operating at the current time. Most of BioLineRx's value examination focuses on studying past and present price action to predict the probability of BioLineRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLineRx's price. Additionally, you may evaluate how the addition of BioLineRx to your portfolios can decrease your overall portfolio volatility.